• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Target ALS

A New York based ALS research organization that's leading the fight for a cure.

  • DONATE
  • About Us
    • Our Mission
    • Our Model
    • Our Impact
    • Our Founder
    • Our Team
    • Our Partners
  • For Scientists
    • Research Cores
      • Target ALS Data Engine
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue Core
      • Stem Cell Core
      • Reagents Core
      • Animal Models Core
    • Funding Opportunities
    • Funded Projects
    • Annual Meeting
    • Science on Target Blog
  • Understanding ALS
    • About ALS
    • Understanding the Science
      • Glossary
      • FAQ
      • ALS 101
    • Voices of ALS
    • Video Library
  • Take Action
    • Support Geoff Greulich
    • The ALS Global Research Initiative (AGRI)
      • Global Natural History Study
      • Community Based Pop-Up Clinics
    • Ways to Give
    • Email Sign Up
    • Contact Us
    • Donate Now
  • News
    • Announcements
    • In the News
    • Newsletters & Reports

Announcements

Target ALS Achieves Extraordinary $250 Million Capital Campaign Goal to Accelerate ALS Research

Stephanie Ishoo · May 7, 2024 ·

Target ALS Launches Groundbreaking Data Portal with DNAstack and Verily to Fuel Breakthroughs in ALS Research 

Stephanie Ishoo · Mar 28, 2024 ·

genetic chains

Target ALS Has Been Named an Official Charity Partner for the 2024 TCS New York City Marathon

Stephanie Ishoo · Mar 12, 2024 ·

NYC Marathon

Biofluid Samples from Target ALS Natural History Study Available for Global Distribution to Advance ALS Research

Stephanie Ishoo · Feb 5, 2024 ·

researcher

Target ALS Celebrates 10 Years: A Decade in Review

Stephanie Ishoo · Dec 1, 2023 ·

10th anniversary

Target ALS Has Been Named an Official Charity Partner for the 2023 TCS New York City Marathon

Melissa Rentfrow · Aug 14, 2023 ·

NYC Marathon

Target ALS and Alzheimer’s Drug Discovery Foundation Announce Award Recipients for Biomarker Research

steckinsights · Aug 30, 2022 ·

Alzheimer's Drug Discovery Foundation

Target ALS Announces New Corporate Council Partnership Opportunity

steckinsights · Jun 9, 2022 ·

Citi

Target ALS Issues Call For Proposals for ALS Biology-Focused Collaborative Projects

steckinsights · May 30, 2022 ·

Target ALS
  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Go to Next Page »

Footer

Target ALS
  • Donate
  • Contact
  • Financial Reports
  • Call For Proposals
  • Annual Meeting
  • Privacy Policy
  • Credits

Follow Us

guidestar

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

© 2023 Target ALS Foundation, Inc.
Target ALS Foundation
244 Madison Avenue #1025
New York, NY 10016
(332) 333-4140
Steck Insights WordPress Consulting

Get our Summer Impact Report in your inbox – a special recap of our Annual Meeting and the progress we're making in ALS research.

Name(Required)
Interests(Required)
Mark the options that best describe your interest in ALS